Hadrup BioMed Holding ApS: Financial statements 2020
CVR: 38034871
Source: annual report 2020, Danish Business Authority
01/01/2020 – 31/12/2020
Hadrup BioMed Holding ApS (CVR 38034871) has filed annual accounts for 2020. In 2020, the company reported a gross profit of DKK -22,500 and a net result of DKK -22,688 compared with DKK 50,000 the year before. Equity in the 2020 report amounted to DKK -12,687.
- Gross Profit
- DKK -22,500
- Profit/Loss
- DKK -22,688
- Equity
- DKK -12,687
- Total Assets
- DKK 99,913
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2020 | - | -23K | -23K | -13K | - |
| 2019 | 0 | 50K | 50K | 90K | - |
| 2018 | 0 | 0 | 0 | 1 | - |
Official annual report
How creditworthy is Hadrup BioMed Holding ApS?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreEvents in 2020
Hadrup BioMed Holding ApS has published its annual report for 2019. Revenue came to DKK 0, and the net result was DKK 50,000.
About Hadrup BioMed Holding ApS
Hadrup BioMed Holding ApS is a Danish company of the type Anpartsselskab based in Virum, founded in 2016. The company is registered under the industry Fremstilling af farmaceutiske præparater. The company was previously named Hadrup BioMed Holding IVS. The management consists of Sine Hadrup. The company is owned by Sine Hadrup. According to the 2025 annual report, the company had an average of 0 employees. In 2025, the company reported a gross profit of DKK -28,316 and a net result of DKK 7,013 compared with DKK 190,306 the year before. Equity in the 2025 report amounted to DKK 2,565,468.
